Ursodiol Tablet, Film Coated
FDA Label NDC 49884-413

28 label sections · Submitted to the FDA by Par Health Usa, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Par Health Usa, Llc for the product Ursodiol (NDC 49884-413). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 general dosing information, 2.2 liver function tests, 2.3 scoring the ursodiol tablets 500 mg, 3 dosage forms and strengths, 4 contraindications, 5.1 abnormal liver function tests, 5.2 enteroliths in patients with risk for intestinal stenosis or stasis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.